Amity Island
Well-Known Member
- Relationship to Diabetes
- Type 1
Mahn has become the first British child to be part of a trial for a revolutionary new drug, teplizumab, which blocks the immune system malfunction that destroys insulin-producing cells and causes type 1 diabetes. The idea is that such drugs will halt the autoimmune disease in its tracks, preventing life-changing symptoms — and the burden on healthcare systems.
Are we proof that a drug to stop diseases like diabetes DOES work?
Mahn Singh is the first British child to be part of a trial for a new drug, teplizumab, which blocks the immune system malfunction that destroys insulin-producing cells and causes type 1 diabetes.
www.dailymail.co.uk